PAMELA SHODA: Open Payments
NPI 1194823989 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,084 in 126 payments from 14 companies in 2025. Trend: 2023 $2,076 · 2024 $1,587 · 2025 $2,084
Food & beverage: $1,927Education: $157
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 55 | $658 |
| UCB, Inc. | 14 | $295 |
| ABBVIE INC. | 25 | $285 |
| GENZYME CORPORATION | 7 | $216 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $209 |
| Galderma Laboratories, L.P. | 2 | $85 |
| Organon LLC | 3 | $61 |
| Lilly USA, LLC | 3 | $60 |
| Arcutis Biotherapeutics, Inc. | 3 | $57 |
| LEO Pharma Inc. | 2 | $56 |
Products named: TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, ILUMYA, NEMLUVIO, VTAMA, Zoryve.
Industry payments across IN — which companies pay providers there.
